PPARD and lung adenocarcinoma: Other research, conducted on PPARβ/δ ligand, L165041 has proved that it inhibits human lung adenocarcinoma cell proliferation29, while the study performed on transgenic mouse model has showed that lack of PPARβ/δ expression is associated with exacerbation of lung cancer32.